Follow
Mats O. Magnusson
Mats O. Magnusson
Senior Consultant, Pharmetheus AB
Verified email at pharmetheus.com - Homepage
Title
Cited by
Cited by
Year
Pharmacodynamics of carbamazepine‐mediated induction of CYP3A4, CYP1A2, and Pgp as assessed by probe substrates midazolam, caffeine, and digoxin
MO Magnusson, ML Dahl, J Cederberg, MO Karlsson, R Sandström
Clinical Pharmacology & Therapeutics 84 (1), 52-62, 2008
1042008
Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment
BJ Brennan, K Wang, S Blotner, MO Magnusson, JJ Wilkins, P Martin, ...
Antimicrobial agents and chemotherapy 57 (12), 6097-6105, 2013
372013
Quantitative analysis of eight testosterone metabolites using column switching and liquid chromatography/tandem mass spectrometry
MO Magnusson, R Sandström
Rapid communications in mass spectrometry 18 (10), 1089-1094, 2004
292004
Population pharmacokinetics of a novel once-every 3 months intramuscular formulation of paliperidone palmitate in patients with schizophrenia
MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ...
Clinical pharmacokinetics 56, 421-433, 2017
282017
Dosing and switching strategies for paliperidone palmitate 3-month formulation in patients with schizophrenia based on population pharmacokinetic modeling and simulation, and …
MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ...
CNS drugs 31 (4), 273-288, 2017
202017
A mechanism-based integrated pharmacokinetic enzyme model describing the time course and magnitude of phenobarbital-mediated enzyme induction in the rat
MO Magnusson, MO Karlsson, R Sandström
Pharmaceutical research 23, 521-532, 2006
132006
Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment
E Sjögren, J Nyberg, MO Magnusson, H Lennernäs, A Hooker, ...
Drug Metabolism and Disposition 39 (5), 858-863, 2011
122011
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
U Schmid, B Weber, MO Magnusson, M Freiwald
Respiratory Medicine 180, 106369, 2021
92021
Population pharmacokinetic modeling of Paliperidone Palmitate 3-month formulation
MO Magnusson, MN Samtani, EL Plan, EN Jonsson, S Rossenu, ...
Population Approach Group in Europe (PAGE) 2015 Meeting, Hersonissos, Greece …, 2015
82015
1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO
M Mirza, D Berton, I Vergote, RD Christensen, A Floquet, J Maenpaa, ...
International Journal of Gynecologic Cancer 31 (Suppl 3), 2021
62021
Development of a population pharmacokinetic model of prucalopride in children with functional constipation
E van Schaick, MA Benninga, A Levine, M Magnusson, S Troy
Pharmacology Research & Perspectives 4 (4), e00236, 2016
62016
PharmTeX: a LaTeX-based open-source platform for automated reporting workflow
CH Rasmussen, MK Smith, K Ito, V Sundararajan, MO Magnusson, ...
The AAPS Journal 20, 1-11, 2018
52018
Pharmacodynamics of enzyme induction and its consequences for substrate elimination
MO Magnusson
Acta Universitatis Upsaliensis, 2007
52007
A MECHANISTIC MODEL TO CHARACTERIZE BINDING DYNAMICS OF AMG 102 TO HGF LIGANDS IN CANCER PATIENTS.
PO Gisleskog, J Lu, JJ PerezRuixo, MO Magnusson, M Zhu
CLINICAL PHARMACOLOGY & THERAPEUTICS 87, S83-S83, 2010
42010
Accuracy of iodine quantification using dual-energy computed tomography with focus on low concentrations
A Ahnfelt, P Dahlman, M Segelsjö, MO Magnusson, A Magnusson
Acta Radiologica 63 (5), 623-631, 2022
32022
Comparison of quality of urinary bladder filling in CT urography with different doses of furosemide in the work-up of patients with macroscopic hematuria
A Ljungberg, M Segelsjö, P Dahlman, M Helenius, M Magnusson, ...
Radiography 27 (1), 136-141, 2021
32021
Population pharmacokinetics of tenecteplase in patients with acute myocardial infarction and application to patients with acute ischemic stroke
F Tang, J Langenhorst, S Dang, N Kassir, R Owen, B Purdon, ...
The Journal of Clinical Pharmacology 63 (2), 197-209, 2023
12023
Translational modeling of regular human insulin pharmacokinetics and glucose dynamics in minipigs
Y Lu, O Alskar, MO Magnusson, P Vaddady, E Carballo-Jane, C Valiathan, ...
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 42, S28-S28, 2015
12015
Population Pharmacokinetics and Exposure‐Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus Erythematosus
C Acharya, MO Magnusson, P Vajjah, R Oliver, M Zamacona
The Journal of Clinical Pharmacology 63 (4), 435-444, 2023
2023
BMS-986036, a PEGylated fibroblast growth factor 21 analogue for the treatment of non-alcoholic steatohepatitis: A population pharmacokinetics and exposure-response analysis
G Tirucherai, M Magnusson, C Acharya, E Charles, D Shevell, R Christian, ...
Journal of Hepatology 68, S409, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20